Last night I had the good fortune of attending our archdiocesan Pallium Lecture. It “is an annual event designed to foster conversation and engage the broader culture through the Catholic intellectual tradition,” per the Milwaukee Archdiocese website. Over the history of the event, the speakers have included Cardinal Dolan and Bishop Barron, among many other…
On January 22, the Catholic Church in the United States observes a “Day of Prayer for the Legal Protection of Unborn Children”. As a past president and former board member of Wisconsin Right to Life, this day is especially meaningful to me. And, somewhat oddly, it inspired me today to share some rather different investment…
Happy New Year! The exclamation is often followed by an inquiry: what are your new year’s resolutions? And every year for millions of Americans (some research says 60% of the population) most of the answers have to do with self-improvement of one type or another. A survey by Forbes done just before year-end showed the…
I have been lucky to have been blessed with seven children. They are now all adults. The majority have yet to start investing for the future despite the occasional admonishment from me. That’s a really bad idea for them and for anyone who has followed the same path. The chart below offers a very simple…
It seems that hardly a day goes by that another major corporation doesn’t pop up with some amazing demonstration of its commitment to the LGBTIQA+ agenda. InBev, owner of Anheuser Busch brand Current star of this phenomenon is Anheuser Busch – InBev, the beer company behind the Budweiser brand. Anheuser, formerly a U.S. company headquartered…
In my last post, I wrote about the change made in January by the Food & Drug Administration (FDA) to its rules regarding the dispensing of Mifepristone, the chemical abortion drug, and the intentions of Walgreens and CVS to distribute it. I am writing today with an update of that article. 21 States said “No!”…
I’d like to start this article by wishing all of you a very happy 2023! Hopefully, it will prove to be more rewarding from an investment standpoint than the exceedingly disappointing 2022. Also disappointing is the recent, January 3rd, policy change by the Food and Drug Administration (FDA) that allows pharmacies to sell mifepristone. What…
I began transforming into a Catholic investor while working as a portfolio manager for Northwestern Mutual Life. I had been a pro-life Catholic for a long time and was serving on the Wisconsin Right to Life Board of Directors. A stockbroker I worked with regularly approached me with a new idea for a stock to…
The London Interbank Offered Rate (Libor) — once called the world’s most important number — is an interest-rate benchmark that has influenced borrowing costs for consumers, businesses, and investors around the world since 1986.1–2 It’s been quoted in five currencies (British pound, Swiss franc, Euro, Japanese yen, and U.S. dollar) from the daily submissions of…
On December 15, 2021, the Federal Open Market Committee (FOMC) of the Federal Reserve System made a significant shift in monetary policy in response to rising inflation. The Committee accelerated the reduction of its bond-buying program in order to tighten the money supply and projected three increases in the benchmark federal funds rate in 2022,…
The SECURE Act (short for Setting Every Community Up for Retirement Enhancement Act) was signed into law by President Trump. It went into effect on Jan. 1. The SECURE Act is the most significant piece of retirement legislation since 2006 and will make it easier for tens of millions of hardworking Americans to save for…
